Autologous Matrix-Induced Chondrogenesis (AMIC) Market Report

Global and Region Autologous Matrix-Induced Chondrogenesis (AMIC) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：211
  • REPORT CODE：GMM938350
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Autologous Matrix-Induced Chondrogenesis (AMIC) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Autologous Matrix-Induced Chondrogenesis (AMIC)market, defines the market attractiveness level of Autologous Matrix-Induced Chondrogenesis (AMIC) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Autologous Matrix-Induced Chondrogenesis (AMIC) industry, describes the types of Autologous Matrix-Induced Chondrogenesis (AMIC) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Autologous Matrix-Induced Chondrogenesis (AMIC) market and the development prospects and opportunities of Autologous Matrix-Induced Chondrogenesis (AMIC) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Autologous Matrix-Induced Chondrogenesis (AMIC) market in Chapter 13.

    By Player:

    • Anika Therapeutics, Inc

    • JRI Orthopaedics Ltd

    • Geistlich Pharma AG

    • Matricel GmbH

    • CartiHeal

    • B Braun Melsungen AG

    • Smith and Nephew plc

    • BioTissue AG

    • Arthro-Kinetics

    • Zimmer Biomet Holdings

    By Type:

    • Hyaluronic Acid

    • Collagen

    • Polyethylene glycol (PEG)

    • polylactic-co-glycolic acid (PGLA)

    • Others

    By End-User:

    • Knee Cartilage Repair

    • Hip Cartilage Repair

    • Elbow Cartilage Repair

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Autologous Matrix-Induced Chondrogenesis (AMIC) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Autologous Matrix-Induced Chondrogenesis (AMIC) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Autologous Matrix-Induced Chondrogenesis (AMIC) Market Analysis and Outlook to 2022

    • 7.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption (2017-2022)

    • 7.2 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption (2017-2022)

    • 7.3 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption (2017-2022)

    • 7.4 China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption (2017-2022)

    • 7.5 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption (2017-2022)

    • 7.6 India Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption (2017-2022)

    • 7.7 South Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption (2017-2022)

    8 Region and Country-wise Autologous Matrix-Induced Chondrogenesis (AMIC) Market Analysis and Outlook to 2028

    • 8.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast (2022-2028)

    • 8.2 United States Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast (2022-2028)

    • 8.3 Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast (2022-2028)

    • 8.4 China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast (2022-2028)

    • 8.5 Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast (2022-2028)

    • 8.6 India Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast (2022-2028)

    • 8.7 South Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast (2022-2028)

    9 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Outlook by Types and Applications to 2022

    • 9.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hyaluronic Acid Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Collagen Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Polyethylene glycol (PEG) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global polylactic-co-glycolic acid (PGLA) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Knee Cartilage Repair Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hip Cartilage Repair Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Elbow Cartilage Repair Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Outlook by Types and Applications to 2028

    • 10.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Hyaluronic Acid Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Collagen Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Polyethylene glycol (PEG) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global polylactic-co-glycolic acid (PGLA) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Knee Cartilage Repair Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hip Cartilage Repair Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Elbow Cartilage Repair Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Autologous Matrix-Induced Chondrogenesis (AMIC) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Competitive Analysis

    • 14.1 Anika Therapeutics, Inc

      • 14.1.1 Anika Therapeutics, Inc Company Details

      • 14.1.2 Anika Therapeutics, Inc Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Anika Therapeutics, Inc Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.2 JRI Orthopaedics Ltd

      • 14.2.1 JRI Orthopaedics Ltd Company Details

      • 14.2.2 JRI Orthopaedics Ltd Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 JRI Orthopaedics Ltd Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.3 Geistlich Pharma AG

      • 14.3.1 Geistlich Pharma AG Company Details

      • 14.3.2 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.4 Matricel GmbH

      • 14.4.1 Matricel GmbH Company Details

      • 14.4.2 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.5 CartiHeal

      • 14.5.1 CartiHeal Company Details

      • 14.5.2 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.6 B Braun Melsungen AG

      • 14.6.1 B Braun Melsungen AG Company Details

      • 14.6.2 B Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 B Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.7 Smith and Nephew plc

      • 14.7.1 Smith and Nephew plc Company Details

      • 14.7.2 Smith and Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Smith and Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.8 BioTissue AG

      • 14.8.1 BioTissue AG Company Details

      • 14.8.2 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.9 Arthro-Kinetics

      • 14.9.1 Arthro-Kinetics Company Details

      • 14.9.2 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • 14.10 Zimmer Biomet Holdings

      • 14.10.1 Zimmer Biomet Holdings Company Details

      • 14.10.2 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Autologous Matrix-Induced Chondrogenesis (AMIC)

    • Figure Autologous Matrix-Induced Chondrogenesis (AMIC) Picture

    • Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Country (2017-2022)

    • Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate (2017-2022)

    • Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate (2017-2022)

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate (2017-2022)

    • Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate (2017-2022)

    • Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption and Growth Rate (2017-2022)

    • Figure Global Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast by Country (2022-2028)

    • Figure United States Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hyaluronic Acid Consumption and Growth Rate (2017-2022)

    • Figure Global Collagen Consumption and Growth Rate (2017-2022)

    • Figure Global Polyethylene glycol (PEG) Consumption and Growth Rate (2017-2022)

    • Figure Global polylactic-co-glycolic acid (PGLA) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Knee Cartilage Repair Consumption and Growth Rate (2017-2022)

    • Figure Global Hip Cartilage Repair Consumption and Growth Rate (2017-2022)

    • Figure Global Elbow Cartilage Repair Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hyaluronic Acid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Collagen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polyethylene glycol (PEG) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global polylactic-co-glycolic acid (PGLA) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Knee Cartilage Repair Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hip Cartilage Repair Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Elbow Cartilage Repair Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Autologous Matrix-Induced Chondrogenesis (AMIC) Export by Region (Top 5 Countries) (2017-2028)

    • Table Anika Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Anika Therapeutics, Inc Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anika Therapeutics, Inc Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table JRI Orthopaedics Ltd (Foundation Year, Company Profile and etc.)

    • Table JRI Orthopaedics Ltd Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table JRI Orthopaedics Ltd Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table Geistlich Pharma AG (Foundation Year, Company Profile and etc.)

    • Table Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Geistlich Pharma AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table Matricel GmbH (Foundation Year, Company Profile and etc.)

    • Table Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Matricel GmbH Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table CartiHeal (Foundation Year, Company Profile and etc.)

    • Table CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CartiHeal Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table B Braun Melsungen AG (Foundation Year, Company Profile and etc.)

    • Table B Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table B Braun Melsungen AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table Smith and Nephew plc (Foundation Year, Company Profile and etc.)

    • Table Smith and Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Smith and Nephew plc Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table BioTissue AG (Foundation Year, Company Profile and etc.)

    • Table BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioTissue AG Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table Arthro-Kinetics (Foundation Year, Company Profile and etc.)

    • Table Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arthro-Kinetics Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service

    • Table Zimmer Biomet Holdings (Foundation Year, Company Profile and etc.)

    • Table Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zimmer Biomet Holdings Autologous Matrix-Induced Chondrogenesis (AMIC) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US